Glaucoma Screening
Not Applicable
Completed
- Conditions
- Glaucoma
- Interventions
- Diagnostic Test: TEMPO iMOvifa
- Registration Number
- NCT06186388
- Lead Sponsor
- Cape Fear Eye Institute
- Brief Summary
* The primary objective of this study is to evaluate the diagnostic accuracy of the TEMPO (iMOvifa) visual field perimeter screening test by measuring the sensitivity in a population of eyes with glaucoma and the specificity in a population of normal eyes and to measure repeatability of the screening test.
* The secondary objective of this study is to gather and analyze ancillary data to confirm the diagnosis or absence of glaucoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Normal TEMPO iMOvifa Subjects with healthy eyes Pathology TEMPO iMOvifa Subjects with glaucoma-affected eyes
- Primary Outcome Measures
Name Time Method Sensitivity and specificity 1 day sensitivity in a population of eyes with glaucoma and specificity in a population of normal eyes
- Secondary Outcome Measures
Name Time Method RNFL and GCL thickness 1 day Using Maestro2 OCT
Trial Locations
- Locations (1)
Cape Fear Eye Institute
🇺🇸Wilmington, North Carolina, United States